These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 2875236)
1. Cyclosporin in therapeutic doses increases renal allograft vascular resistance. Curtis JJ; Luke RG; Dubovsky E; Diethelm AG; Whelchel JD; Jones P Lancet; 1986 Aug; 2(8505):477-9. PubMed ID: 2875236 [TBL] [Abstract][Full Text] [Related]
2. Cyclosporin treatment with conversion after three months versus conventional immunosuppression in renal allograft recipients. Hoitsma AJ; Wetzels JF; van Lier HJ; Berden JH; Koene RA Lancet; 1987 Mar; 1(8533):584-6. PubMed ID: 2881130 [TBL] [Abstract][Full Text] [Related]
3. A single institution, randomized, prospective trial of cyclosporin versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients. Najarian JS; Fryd DS; Strand M; Canafax DM; Ascher NL; Payne WD; Simmons RL; Sutherland DE Ann Surg; 1985 Feb; 201(2):142-57. PubMed ID: 3882063 [TBL] [Abstract][Full Text] [Related]
4. Triple therapy and initial renal graft perfusion. Thomsen HS; Nielsen SL Dan Med Bull; 1988 Aug; 35(4):393-5. PubMed ID: 3048925 [TBL] [Abstract][Full Text] [Related]
5. Safe conversion from cyclosporine to azathioprine with improved renal function in pediatric renal transplantation. Kaiser BA; Lawless ST; Palmer JM; Dunn SP; Polinsky MS; Baluarte HJ Pediatr Nephrol; 1989 Oct; 3(4):401-5. PubMed ID: 2642107 [TBL] [Abstract][Full Text] [Related]
6. [Cyclosporin A in preventive therapy after kidney transplantation: a double combination versus a triple combination. I. Therapeutic effectiveness]. Matl I; Jirka J; Kocandrle V; Petrásek R Cas Lek Cesk; 1990 May; 129(18):550-3. PubMed ID: 2350773 [TBL] [Abstract][Full Text] [Related]
7. Cyclosporin A for immunosuppression: observations in rat heart, pancreas, and islet allograft models and in human renal and pancreas transplantation. Rynasiewicz JJ; Sutherland DE; Ferguson RM; Squifflet JP; Morrow CE; Goetz FC; Najarian JS Diabetes; 1982 Aug; 31 Suppl 4():92-108. PubMed ID: 6819969 [TBL] [Abstract][Full Text] [Related]
9. Selective conversion from azathioprine to cyclosporin for steroid-resistant rejection in renal transplants: an alternative therapy. Crowson MC; Berisa F; McGonigle RJ; Adu D; Michael J; Barnes AD Nephrol Dial Transplant; 1989; 4(2):129-32. PubMed ID: 2496354 [TBL] [Abstract][Full Text] [Related]
10. The effect of conversion from cyclosporin to azathioprine on renin-containing cells in renal allograft biopsies. Gardiner DS; Watson MA; Junor BJ; Briggs JD; More IA; Lindop GB Nephrol Dial Transplant; 1991; 6(5):363-7. PubMed ID: 1870754 [TBL] [Abstract][Full Text] [Related]
11. Conversion from cyclosporin to azathioprine 3 months after renal transplantation--is it safe? Cassidy MJ; Irving E; Swanepoel CR; Pascoe MD; van Zyl-Smit R; Jacobson JE S Afr Med J; 1986 Sep; 70(6):317-8. PubMed ID: 3529454 [TBL] [Abstract][Full Text] [Related]